gadolinium has been researched along with Liver Dysfunction in 106 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (4.72) | 18.7374 |
1990's | 48 (45.28) | 18.2507 |
2000's | 38 (35.85) | 29.6817 |
2010's | 14 (13.21) | 24.3611 |
2020's | 1 (0.94) | 2.80 |
Authors | Studies |
---|---|
Arai, S; Arakawa, H; Asami, Y; Hatakeyama, S; Ikeda, K; Kobayashi, T; Miyamoto, T; Nakajima, K; Okada, Y; Seki, M; Shimoyama, S; Takizawa, T; Tanaka, K | 1 |
Dahi, F; Jiang, Y; Oto, A; Rist, C; Schmid-Tannwald, C; Sethi, I | 1 |
Bianco, R; Crespi, M; Tonolini, M | 1 |
Fet, N; Hata, K; Klinge, U; Minor, T; Nakajima, A; Okamura, Y; Taura, K; Tolba, RH; Uchinami, H; Yamamoto, Y; Yamaoka, Y; Yonezawa, K | 1 |
Deshmukh, S; Guglielmo, FF; Mitchell, DG; Roth, CG | 1 |
Bashir, MR | 1 |
Hernando, D; Reeder, SB; Vigen, KK; Wells, SA | 1 |
Higaki, A; Ito, K; Kanki, A; Nishimura, H; Noda, Y; Sato, T; Tamada, T; Watanabe, S; Yamamoto, A | 1 |
Sato, T | 1 |
Agris, J; Endrikat, J; Pietsch, H; Sieber, MA | 1 |
Gong, JP; He, K; Li, PZ; Miao, CM; Ou, ZB; Xing, DP; Ye, MX; Zhu, RT | 1 |
Buckley, DL; Chrysochou, C; Cowie, A; Dark, P; Kalra, PA | 1 |
Goshima, S; Kanematsu, M; Kondo, H; Moriyama, N; Onozuka, M; Shiratori, Y; Tsuge, Y; Watanabe, H | 1 |
Fortunato, F; Fritz, S; Gebhard, MM; Hackert, T; Hartwig, W; Krych, R; Longerich, T; Schneider, L; Werner, J | 1 |
Barrau, V; Beers, BV; Meskine, N; Piana, G; Trinquart, L; Vilgrain, V | 1 |
Neil Granger, D; Singer, G; Stokes, KY | 1 |
Lebedis, C; Luna, A; Soto, JA | 1 |
Bourdi, M; Brady, JN; George, JW; Ju, C; Pohl, LR; Radonovich, MF; Reilly, TP | 1 |
Baba, S; Konno, H; Kurachi, K; Nakamura, S; Sakaguchi, T; Suzuki, S; Yokoi, Y | 1 |
Amano, M; Amano, Y; Kumazaki, T; Nozaki, A; Takahama, K | 1 |
Reimer, P; Schima, W; Schneider, G | 1 |
Braga, L; Danet, MI; Kanematsu, M; Leonardou, P; Mastropasqua, M; Mosetti, MA; Semelka, RC; Woosley, JT | 1 |
Fukuda, M; Horie, Y; Ishii, H; Kamegaya, Y; Kato, S; Mizukami, T; Ohgo, H; Okamura, Y; Yokoyama, H | 1 |
Ba-Ssalamah, A; Dirisamer, A; Happel, B; Kettenbach, J; Längle, F; Schima, W; Wrba, F | 1 |
Bellin, MF; Morcos, SK; Thomsen, HS; Van Der Molen, AJ; Webb, JA | 1 |
McMurry, TJ; Nair, SA; Zhang, Z | 1 |
Martin, DR; Semelka, RC | 2 |
Balci, NC; Semelka, RC | 1 |
Jung, JY; Lee, SM | 1 |
Andronikou, S; Lakhoo, K; Nafoos, O; Platt, K; Soin, S | 1 |
Fukuda, Y; Ikemoto, M; Murayama, H; Nagata, A; Tsunekawa, S | 1 |
Goshima, S; Kajita, K; Kanematsu, M; Kondo, H; Moriyama, N; Onozuka, M; Suzuki, Y; Tsuge, Y; Van Cauteren, M; Yokoyama, R | 1 |
Li, X; Liao, P; Ni, J; Pei, F; Wei, L; Wu, H; Wu, Y; Zhang, X | 1 |
Abdel-Rahman, MM; Abdel-Zaher, AO; Hafez, MM; Omran, FM | 1 |
Altun, E; Herédia, V; Ramalho, M; Semelka, R; Zapparoli, M | 1 |
Hussain, SM; Krestin, GP; Pattynama, PM; Van den Bos, IC; Vogel, MW; Wang, L | 1 |
Altun, E; Dale, BM; Elias, J; Gasparetto, EL; Pamuklar, E; Semelka, RC; Tsurusaki, M; Zapparoli, M | 1 |
Nelson, RC; Saini, S | 1 |
De Franco, A; De Gaetano, AM; Manfredi, R; Marano, P; Maresca, G | 1 |
Adachi, Y; Arii, S; Fujita, S; Funaki, N; Furutani, M; Higashitsuji, H; Ishiguro, S; Kitao, T; Mise, M; Monden, K | 2 |
Saini, S | 1 |
Ganey, PE; Schultze, AE | 1 |
Larson, RE; Semelka, RC | 1 |
Brown, ED; Semelka, RC | 1 |
Mitchell, DG; Mohamed, F; Ortega, H; Tascyian, T; Vinitski, S | 1 |
Schnall, M | 1 |
Sauer, JM; Sipes, IG | 1 |
Balzer, T; Berns, T; Daldrup, HE; Hesse, T; Peters, PE; Reimer, P; Rummeny, EJ; Shamsi, K; Tombach, B | 1 |
Balzer, T; Bechstein, WO; Felix, R; Hammerstingl, R; Kümmel, S; Mack, MG; Müller, PK; Schellenbeck, M; Schumacher, G; Schwarz, W; Söllner, O; Vogl, TJ | 1 |
Mitchell, DG | 1 |
Giovagnoni, A; Paci, E | 1 |
Brown, ED; Eisenberg, LB; Kettritz, U; Schlund, JF; Semelka, RC; Warshauer, DM | 1 |
Awaya, H; Fujita, T; Honjo, K; Ito, K; Koike, S; Matsumoto, T; Matsunaga, N; Mitchell, DG; Takano, K | 1 |
Balzer, JO; Balzer, T; Bechstein, WO; Felix, R; Hammerstingl, R; Kümmel, S; Lauten, MJ; Mack, MG; Müller, PK; Neuhaus, P; Schimpfky, C; Schrem, H; Schwarz, W; Vogl, TJ | 1 |
DeCorato, DR; Earls, JP; Krinsky, GA; Rofsky, NM; Weinreb, JC | 1 |
Eisenberg, LB; Kettritz, U; Schlund, JF; Semelka, RC; Wilbur, K | 1 |
Hamm, B; Mahfouz, AE | 1 |
Blakeborough, A; Griffiths, M; Guthrie, JA; Kajiya, Y; Robinson, PJ; Ward, J; Wilson, D | 1 |
Atilla, S; Borrello, JA; Brown, JJ; Pilgram, TK; Quillin, SP; Yu, CY | 1 |
Bernelli-Zazzera, A; Pogliaghi, G; Radice, L; Tacchini, L | 1 |
Runge, VM | 2 |
Hooser, SB; Kuester, RK; McQueen, CA; Sauer, JM; Sipes, IG; Waalkes, MP | 1 |
Gouhiri, M; Rondeau, Y; Rymer, R; Scherrer, A; Soyer, P; Spelle, L | 1 |
He, CY; Kay, MA; Kirillova, I; Lieber, A; Meuse, L; Schowalter, D; Winther, B | 1 |
Van Beers, B | 1 |
Hahn, PF; Saini, S | 1 |
Davies, A; Kirchin, M; Lorusso, V; Pirovano, G; Spinazzi, A; Taroni, P | 1 |
Low, RN | 3 |
Marchal, G; Ni, Y | 1 |
Noda, T; Shimizu, M; Yamano, T | 1 |
Kirchin, MA; Pirovano, GP; Spinazzi, A | 1 |
Cui, TX; Iwai, M; Shimazu, T; Yamauchi, T | 1 |
Harpur, E; Spencer, A; Wilson, S | 1 |
Essig, M; Hawighorst, H; Knopp, MV; Miltner, P; Schoenberg, SO; van Kaick, G | 1 |
Borrello, JA; Brown, JJ; Pawluk, RS; Tummala, S | 1 |
Baker, JF; Barr, R; Barr, W; Barron, B; Free, R; Gazelle, GS; Lambrecht, LJ; Maravilla, KR; Pierro, JA; Seltzer, S; Stevens, GR; Swan, SK; Tucker, RM | 1 |
Boudghène, F | 1 |
Clément, O; Cuénod, CA; Frija, G; Leconte, I; Siauve, N; Vuillemin-Bodaghi, V | 1 |
Grazioli, L; Kirchin, M; Pirovano, G; Spinazzi, A | 1 |
de Haën, C; La Ferla, R; Maggioni, F | 1 |
Kurkchubasche, AG; Papa, EF; Roggin, KK; Tracy, TF | 1 |
Macdonald, GA; Peduto, AJ | 1 |
Balci, NC; Chung, JJ; Martin, DR; Semelka, RC; Wilber, K | 1 |
Ly, JN; Miller, FH | 1 |
Beavers, KL; Semelka, RC | 1 |
Crockett, E; Dean, R; Harkema, J; Mosher, B; Palma, J; Remick, D | 1 |
Tanimoto, A | 1 |
Robinson, PJ; Ward, J | 1 |
de Hemptinne, B; Elewaut, A; Mortelé, KJ; Praet, M; Ros, PR; Wiesner, W | 1 |
Fisher, AR; Siegelman, ES | 1 |
Bensel, K; Davies, A; Davies, BE; Kirchin, MA; Lafrance, ND; Lorusso, V; Parker, JR | 1 |
Marinelli, ER; Neubeck, R; Nunn, A; Ranganathan, RS; Runge, V; Song, B; Sukumaran, K; Tweedle, M; Wagler, T; Wedeking, P | 1 |
Bautz, W; Dobritz, M; Fellner, FA; Nittka, M; Radkow, T | 1 |
Greenberg, HM; Kroeker, MA; Kroeker, RM; Micflikier, AB; Minuk, GY; Semelka, RC; Shoenut, JP; Simm, FC | 1 |
Vellet, AD | 1 |
Hahn, D; Lissner, J; Schedel, H; Steiner, S; Vogl, T | 1 |
Felix, R; Hamm, B; Wolf, KJ | 1 |
Felix, R; Hamm, B; Römer, T; Wolf, KJ | 1 |
Gotoh, H; Iio, M; Mano, I; Miyagawa, S; Nakabayashi, K; Yashiro, N; Yoshida, H | 1 |
Kozlova, MD; Levin, VI; Prokof'eva, ISh; Sedova, TS; Tarasov, NF | 1 |
Lefebvre, F; Selye, H; Szabo, S; Tuchweber, B | 1 |
32 review(s) available for gadolinium and Liver Dysfunction
Article | Year |
---|---|
Hepatic MR imaging techniques, optimization, and artifacts.
Topics: Artifacts; Contrast Media; Diffusion Magnetic Resonance Imaging; Gadolinium; Humans; Image Enhancement; Imaging, Three-Dimensional; Liver; Liver Diseases; Magnetic Resonance Imaging | 2014 |
Magnetic resonance contrast agents for liver imaging.
Topics: Contrast Media; Gadolinium; Humans; Image Enhancement; Liver; Liver Diseases; Magnetic Resonance Imaging | 2014 |
Gadolinium-enhanced magnetic resonance imaging for renovascular disease and nephrogenic systemic fibrosis: critical review of the literature and UK experience.
Topics: Contrast Media; Gadolinium; Glomerular Filtration Rate; Humans; Kidney Diseases; Liver Diseases; Magnetic Resonance Angiography; Nephrogenic Fibrosing Dermopathy; Prognosis; United Kingdom | 2009 |
Use of magnetic resonance imaging contrast agents in the liver and biliary tract.
Topics: Biliary Tract Diseases; Contrast Media; Gadolinium; Humans; Image Enhancement; Liver Diseases; Magnetic Resonance Imaging | 2012 |
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Meglumine; Organometallic Compounds; Pyridoxal Phosphate; Time Factors; Tomography, X-Ray Computed | 2004 |
[MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents].
Topics: Chelating Agents; Contrast Media; Edetic Acid; Gadolinium; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Practice Patterns, Physicians'; Pyridoxal Phosphate | 2004 |
Safety of MR liver specific contrast media.
Topics: Biliary Tract Diseases; Contrast Media; Dextrans; Ferrosoferric Oxide; Gadolinium; Humans; Iron; Liver; Liver Diseases; Magnetic Resonance Imaging; Magnetite Nanoparticles; Manganese; Oxides | 2005 |
Gadolinium meets medicinal chemistry: MRI contrast agent development.
Topics: Chelating Agents; Contrast Media; Drug Design; Gadolinium; Humans; Liver Diseases; Magnetic Resonance Imaging; Molecular Structure; Organometallic Compounds; Radiopharmaceuticals; Vascular Diseases | 2005 |
Magnetic resonance imaging of the liver: review of techniques and approach to common diseases.
Topics: Contrast Media; Fatty Liver; Gadolinium; Hemochromatosis; Hepatitis; Humans; Image Enhancement; Liver; Liver Diseases; Magnetic Resonance Imaging | 2005 |
Contrast agents for MR imaging of the liver.
Topics: Contrast Media; Gadolinium; Humans; Image Enhancement; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging | 2005 |
Liver MR imaging: 1.5T versus 3T.
Topics: Artifacts; Contrast Media; Echo-Planar Imaging; Gadolinium; Humans; Image Enhancement; Imaging, Three-Dimensional; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging | 2007 |
Post-processing of dynamic gadolinium-enhanced magnetic resonance imaging exams of the liver: explanation and potential clinical applications for color-coded qualitative and quantitative analysis.
Topics: Adult; Color; Contrast Media; Female; Gadolinium; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Time Factors | 2008 |
Magnetic resonance imaging of the liver.
Topics: Contrast Media; Gadolinium; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Sensitivity and Specificity | 1995 |
Contrast-enhanced magnetic resonance imaging of the abdomen.
Topics: Abdomen; Contrast Media; Gadolinium; Gastrointestinal Diseases; Humans; Image Enhancement; Kidney Diseases; Liver Diseases; Magnetic Resonance Imaging; Pancreatic Diseases | 1994 |
Magnetic resonance imaging of focal liver lesions.
Topics: Contrast Media; Echo-Planar Imaging; Gadolinium; Humans; Image Enhancement; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging | 1995 |
Liver I: Currently available gadolinium chelates.
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1996 |
Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).
Topics: Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Multicenter Studies as Topic; Organometallic Compounds; Pentetic Acid; Safety | 1996 |
MR imaging of the liver. Contrast agents.
Topics: Contrast Media; Gadolinium; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging | 1997 |
Liver MRI with contrast enhancement.
Topics: Clinical Trials as Topic; Contrast Media; Gadolinium; Humans; Iron Compounds; Liver; Liver Diseases; Magnetic Resonance Imaging; Manganese Compounds | 1997 |
Liver-specific MR imaging contrast agents.
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Humans; Iron; Liver; Liver Diseases; Magnetic Resonance Imaging; Magnetite Nanoparticles; Oxides; Pyridoxal Phosphate | 1998 |
Current uses of gadolinium chelates for clinical magnetic resonance imaging examination of the liver.
Topics: Chelating Agents; Contrast Media; Gadolinium; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging | 1998 |
Gadobenate dimeglumine (Gd-BOPTA). An overview.
Topics: Animals; Central Nervous System Diseases; Contrast Media; Gadolinium; Heart Diseases; Humans; Liver Diseases; Magnetic Resonance Angiography; Meglumine; Organometallic Compounds | 1998 |
Mechanisms of action of liver contrast agents: impact for clinical use.
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Humans; Injections, Intravenous; Iron; Kupffer Cells; Liver; Liver Diseases; Magnetic Resonance Imaging; Magnetite Nanoparticles; Manganese; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate | 1999 |
Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) as contrast agent for magnetic resonance imaging of the liver: mechanistic studies in animals.
Topics: Animals; Biological Transport; Contrast Media; Diagnosis, Differential; Disease Models, Animal; Gadolinium; Injections, Intravenous; Liver; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 1999 |
Magnetic resonance imaging (MRI) and diseases of the liver and biliary tract. Part 1. Basic principles, MRI in the assessment of diffuse and focal hepatic disease.
Topics: Biliary Tract Diseases; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Gadolinium; Hemangioma, Cavernous; Humans; Iron Compounds; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Sensitivity and Specificity; Tomography, X-Ray Computed | 2000 |
MRI evaluation of the liver.
Topics: Contrast Media; Gadolinium; Humans; Liver Diseases; Magnetic Resonance Imaging; Sensitivity and Specificity | 2001 |
[Liver-specific MR contrast agents: current status and prospects].
Topics: Contrast Media; Ferric Compounds; Ferrosoferric Oxide; Gadolinium; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging | 2001 |
MR imaging of the liver using gadolinium chelates.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Gadolinium; Humans; Injections, Intravenous; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging | 2001 |
Imaging of benign and malignant focal liver lesions.
Topics: Contrast Media; Diagnosis, Differential; Gadolinium; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Sensitivity and Specificity; Tomography, X-Ray Computed | 2001 |
Gadolinium-enhanced MR imaging of liver capsule and peritoneum.
Topics: Contrast Media; Gadolinium; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Peritoneal Cavity; Peritoneal Diseases; Peritoneal Neoplasms; Peritoneum | 2001 |
Magnetic resonance imaging techniques.
Topics: Contrast Media; Gadolinium; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging | 2002 |
Characterization of intrahepatic space-occupying lesions by magnetic resonance imaging.
Topics: Carcinoma, Hepatocellular; Cysts; Gadolinium; Hematoma; Humans; Hyperplasia; Image Enhancement; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging | 1991 |
7 trial(s) available for gadolinium and Liver Dysfunction
Article | Year |
---|---|
Gadolinium-enhanced multiphasic 3D MRI of the liver with prospective adaptive navigator correction: phantom study and preliminary clinical evaluation.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium; Humans; Imaging, Three-Dimensional; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Phantoms, Imaging; Retrospective Studies | 2007 |
Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.
Topics: Contrast Media; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid; Time Factors | 1996 |
Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Hemangioma; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies | 1996 |
Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Topics: Carcinoma, Hepatocellular; Contrast Media; Dextrans; Ferrosoferric Oxide; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Hemangioma; Humans; Iron; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Organometallic Compounds; Oxides; Pentetic Acid; Prospective Studies; Suspensions | 1996 |
Pharmacokinetics, safety, and tolerability of gadoversetamide injection (OptiMARK) in subjects with central nervous system or liver pathology and varying degrees of renal function.
Topics: Adult; Central Nervous System; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium; Humans; Injections, Intravenous; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Renal Insufficiency; Safety | 1999 |
MultiHance in the dynamic phase of contrast enhancement: a pictorial assessment.
Topics: Adenoma; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diagnosis, Differential; Focal Nodular Hyperplasia; Gadolinium; Hemangioma; Humans; Injections, Intravenous; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Prospective Studies | 1999 |
Pharmacokinetics and safety of gadobenate dimeglumine (multihance) in subjects with impaired liver function.
Topics: Adult; Contrast Media; Double-Blind Method; Female; Gadolinium; Humans; Liver; Liver Diseases; Male; Meglumine; Middle Aged; Organometallic Compounds | 2002 |
67 other study(ies) available for gadolinium and Liver Dysfunction
Article | Year |
---|---|
Visual liver assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging of patients in the early post-Fontan period.
Topics: Child; Child, Preschool; Female; Gadolinium; Humans; Liver Diseases; Magnetic Resonance Imaging; Male; Pentetic Acid; Retrospective Studies | 2020 |
Diffusion-weighted MR imaging of focal liver lesions in the left and right lobes: is there a difference in ADC values?
Topics: Adult; Aged; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Male; Meglumine; Middle Aged; Organometallic Compounds | 2013 |
Magnetic resonance imaging clinches diagnosis of haemorrhagic liver cyst.
Topics: Contrast Media; Cysts; Female; Gadolinium; Hemorrhage; Humans; Liver Diseases; Magnetic Resonance Imaging; Middle Aged | 2013 |
Role of preferential cyclooxygenase-2 inhibition by meloxicam in ischemia/reperfusion injury of the rat liver.
Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Evaluation, Preclinical; Gadolinium; In Situ Nick-End Labeling; Kidney Function Tests; Kupffer Cells; Liver; Liver Diseases; Male; Meloxicam; Rats, Wistar; Reperfusion Injury; Thiazines; Thiazoles; Thromboxane B2; Tumor Necrosis Factor-alpha | 2014 |
Effect of hepatocyte-specific gadolinium-based contrast agents on hepatic fat-fraction and R2(⁎).
Topics: Adult; Aged; Aged, 80 and over; Bilirubin; Contrast Media; End Stage Liver Disease; Female; Gadolinium; Gadolinium DTPA; Hepatocytes; Humans; Image Processing, Computer-Assisted; Linear Models; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Tomography, X-Ray Computed; Ultrasonography; Water; Young Adult | 2015 |
Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
Topics: Animals; Carbon Tetrachloride Poisoning; Contrast Media; Gadolinium; Gadolinium DTPA; Kidney Diseases; Liver Cirrhosis; Liver Diseases; Male; Mass Spectrometry; Nephrectomy; Rats; Rats, Wistar | 2015 |
Response to the Comments by Dr. Endrikat et al. on the article "Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS)" by Tomohiro Sato, Tsutomu Tamada, Sh
Topics: Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Kidney Diseases; Liver Diseases; Male | 2016 |
Comments on the article "Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS)" by Tomohiro Sato, Tsutomu Tamada, Shigeru Watanabe et al. DOI 10.1007/s1154
Topics: Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Kidney Diseases; Liver Diseases; Male | 2016 |
Investigation for role of tissue factor and blood coagulation system in severe acute pancreatitis and associated liver injury.
Topics: Aged; Animals; Blood Coagulation; Female; Gadolinium; Humans; Kupffer Cells; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Middle Aged; Pancreatitis; RNA, Messenger; Thromboplastin; Up-Regulation | 2017 |
Detection and grading for esophageal varices in patients with chronic liver damage: comparison of gadolinium-enhanced and unenhanced steady-state coherent MR images.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Endoscopy; Esophageal and Gastric Varices; Female; Gadolinium; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; ROC Curve | 2009 |
Effects of gadolinium chloride and glycine on hepatic and pancreatic tissue damage in alcoholic pancreatitis.
Topics: Analysis of Variance; Animals; Ethanol; Gadolinium; Glycine; Glycine Agents; Liver; Liver Circulation; Liver Diseases; Male; Pancreas; Pancreatitis, Acute Necrotizing; Pancreatitis, Alcoholic; Rats; Rats, Wistar | 2010 |
New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Diffusion Magnetic Resonance Imaging; Fatty Liver; Female; Gadolinium; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Cirrhosis, Alcoholic; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Observer Variation | 2011 |
Reactive oxygen and nitrogen species in sepsis-induced hepatic microvascular dysfunction.
Topics: Alanine Transaminase; Animals; Blood Pressure; Cell Adhesion; Cell Count; Cytokines; Gadolinium; Leukocyte Count; Liver Diseases; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; NADPH Oxidase 2; NADPH Oxidases; Nitric Oxide Synthase; Platelet Count; Reactive Nitrogen Species; Reactive Oxygen Species; Sepsis; Superoxide Dismutase | 2013 |
Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice.
Topics: Acetaminophen; Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Clodronic Acid; Complement C1q; Cyclooxygenase 2; Cytokines; Female; Gadolinium; Gene Expression; Inflammation Mediators; Isoenzymes; Kupffer Cells; Liposomes; Liver Diseases; Mice; Mice, Inbred C57BL; Mice, Knockout; Prostaglandin-Endoperoxide Synthases; RNA, Messenger | 2002 |
Kupffer cells modulate splenic interleukin-10 production in endotoxin-induced liver injury after partial hepatectomy.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Gadolinium; Gene Expression; Hepatectomy; Interleukin-10; Kupffer Cells; Lipopolysaccharides; Liver Diseases; Male; Rats; Rats, Wistar; RNA, Messenger; Spleen; Tumor Necrosis Factor-alpha | 2003 |
Magnetic resonance portography using contrast-enhanced fat-saturated three-dimensional steady-state free precession imaging.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Chronic Disease; Contrast Media; Feasibility Studies; Female; Gadolinium; Hemangioma; Humans; Image Enhancement; Imaging, Three-Dimensional; Liver Diseases; Liver Neoplasms; Magnetic Resonance Angiography; Male; Middle Aged; Portography; Stomach Neoplasms | 2004 |
Early heterogeneous enhancement of the liver: magnetic resonance imaging findings and clinical significance.
Topics: Adolescent; Adult; Aged; Contrast Media; Female; Gadolinium; Humans; Image Enhancement; Liver; Liver Diseases; Liver Function Tests; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies | 2004 |
Kupffer cell depletion attenuates superoxide anion release into the hepatic sinusoids after lipopolysaccharide treatment.
Topics: Animals; Antioxidants; Endotoxemia; Gadolinium; Kupffer Cells; Lipopolysaccharides; Liver; Liver Diseases; Male; Models, Animal; Oxidative Stress; Perfusion; Rats; Rats, Wistar; Superoxides | 2004 |
The roles of Kupffer cells in hepatic dysfunction induced by ischemia/reperfusion in rats.
Topics: Alanine Transaminase; Aminopyrine N-Demethylase; Aniline Hydroxylase; Animals; Bile; Cholates; Cytochrome P-450 Enzyme System; Disease Models, Animal; Gadolinium; Kupffer Cells; Liver; Liver Diseases; Male; Malondialdehyde; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2005 |
Hepatic mesenchymal hamartoma mimicking hemangioma on multiple-phase gadolinium-enhanced MRI.
Topics: alpha-Fetoproteins; Diagnosis, Differential; Gadolinium; Hamartoma; Hemangioma; Humans; Infant; Liver Diseases; Magnetic Resonance Imaging; Male; Mesoderm | 2006 |
Serum level of ornithine carbamoyltransferase is influenced by the state of Kupffer cells.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Gadolinium; Glutamate Dehydrogenase; Hepatocytes; Kupffer Cells; Lipopolysaccharides; Liver; Liver Diseases; Male; Ornithine Carbamoyltransferase; Rats; Rats, Wistar; Thioacetamide | 2007 |
Metabolic profiling of serum from gadolinium chloride-treated rats by 1H NMR spectroscopy.
Topics: Alanine; Amino Acids; Animals; Biomarkers; Blood Glucose; Chemical and Drug Induced Liver Injury; Creatine; Dose-Response Relationship, Drug; Gadolinium; gamma-Glutamyltransferase; Injections, Intraperitoneal; L-Lactate Dehydrogenase; Lactic Acid; Liver; Liver Diseases; Magnetic Resonance Spectroscopy; Male; Methylamines; Models, Animal; Principal Component Analysis; Rats; Rats, Wistar; Serum | 2007 |
Role of nitric oxide and reduced glutathione in the protective effects of aminoguanidine, gadolinium chloride and oleanolic acid against acetaminophen-induced hepatic and renal damage.
Topics: Acetaminophen; Administration, Oral; Alanine Transaminase; Alkaline Phosphatase; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Creatinine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gadolinium; Glutathione; Guanidines; Injections, Intramuscular; Kidney Diseases; Liver Diseases; Male; Nitric Oxide; Oleanolic Acid; Protective Agents; Rats; Rats, Wistar; Survival Analysis; Survival Rate | 2007 |
3.0-T MRI evaluation of patients with chronic liver diseases: initial observations.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Chi-Square Distribution; Chronic Disease; Contrast Media; Female; Gadolinium; Humans; Imaging, Three-Dimensional; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies | 2008 |
Technique for MR imaging of the liver.
Topics: Adipose Tissue; Adult; Artifacts; Contrast Media; Gadolinium; Hemangioma; Humans; Image Enhancement; Injections, Intravenous; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Time Factors | 1995 |
[The tissue characterization of focal liver lesions with magnetic resonance imaging].
Topics: Biopsy, Needle; Contrast Media; Diagnosis, Differential; Gadolinium; Gadolinium DTPA; Humans; Hyperplasia; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Prospective Studies; Radionuclide Imaging; Technetium; Ultrasonography | 1995 |
Participation of hepatic macrophages and plasma factors in endotoxin-induced liver injury.
Topics: Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Endotoxins; Gadolinium; L-Lactate Dehydrogenase; Lipopolysaccharides; Liver; Liver Diseases; Macrophages; Male; Rats; Rats, Wistar; RNA, Messenger; Tumor Necrosis Factor-alpha | 1995 |
Should Gd chelates be used routinely for liver MR imaging?
Topics: Contrast Media; Gadolinium; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging | 1995 |
Depletion of neutrophils and modulation of Kupffer cell function in allyl alcohol-induced hepatotoxicity.
Topics: 1-Propanol; Animals; Chemical and Drug Induced Liver Injury; Cyclophosphamide; Drug Interactions; Female; Gadolinium; Kupffer Cells; Leukocytes; Liver Diseases; Male; Neutrophils; Propanols; Rabbits; Rats; Rats, Sprague-Dawley | 1995 |
Identification of the thromboxane A2 receptor in hepatic sinusoidal endothelial cells and its role in endotoxin-induced liver injury in rats.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cyclooxygenase Inhibitors; Endothelium, Vascular; Endotoxins; Gadolinium; Kupffer Cells; Lipopolysaccharides; Liver Circulation; Liver Diseases; Male; Rats; Rats, Wistar; Receptors, Thromboxane | 1994 |
Aortic ghost artifact in ultrashort TE multislice gradient echo MR images is not increased by paramagnetic enhancement.
Topics: Aorta, Abdominal; Artifacts; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Models, Cardiovascular; Models, Structural; Organometallic Compounds; Pentetic Acid; Pulsatile Flow; Time Factors | 1993 |
Modulation of chemical-induced lung and liver toxicity by all-trans-retinol in the male Sprague-Dawley rat.
Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Drug Synergism; Gadolinium; Liver; Liver Diseases; Lung; Lung Diseases; Male; Naphthalenes; Paraquat; Rats; Rats, Sprague-Dawley; Vitamin A | 1995 |
Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate.
Topics: Adipose Tissue; Adult; Aged; Contrast Media; Edetic Acid; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Injections, Intravenous; Liver Diseases; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Organometallic Compounds; Pancreas; Pentetic Acid; Pyridoxal Phosphate | 1996 |
Gadolinium-enhanced MR imaging of the spleen: artifacts and potential pitfalls.
Topics: Aged; Artifacts; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Spleen; Splenic Diseases | 1996 |
Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Hepatic Artery; Humans; Injections; Liver; Liver Circulation; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Portal Vein | 1997 |
Comparison of gadolinium chelates with manganese-DPDP for liver lesion detection and characterization: preliminary results.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Cysts; Edetic Acid; Female; Gadolinium; Gadolinium DTPA; Hemangioma; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies; Pyridoxal Phosphate; Tomography, X-Ray Computed | 1996 |
Hepatic lesion detection at MR imaging: a comparative study with four sequences.
Topics: Adipose Tissue; Adult; Aged; Area Under Curve; Contrast Media; Drug Combinations; Female; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Hepatectomy; Humans; Image Enhancement; Image Processing, Computer-Assisted; Iron; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Oxides; Pentetic Acid; Preoperative Care; ROC Curve; Sensitivity and Specificity; Single-Blind Method | 1997 |
Characterization of focal hepatic masses by dynamic contrast-enhanced MR imaging: findings in 311 lesions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Cysts; Drug Combinations; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Hemangioma, Cavernous; Hepatic Artery; Humans; Image Enhancement; Injections, Intra-Arterial; Injections, Intravenous; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Respiration; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method | 1997 |
Differential activation of heat shock and nuclear factor kappaB transcription factors in postischemic reperfused rat liver.
Topics: Acetylcysteine; Animals; Free Radical Scavengers; Gadolinium; Heat-Shock Proteins; Liver Diseases; Male; NF-kappa B; Rats; Rats, Wistar; Receptors, Interleukin-1; Reperfusion Injury | 1997 |
Suppression of Kupffer cell function prevents cadmium induced hepatocellular necrosis in the male Sprague-Dawley rat.
Topics: Alanine Transaminase; Animals; Cadmium Chloride; Carcinogens; Cells, Cultured; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Gadolinium; Gout Suppressants; Injections, Intravenous; Kupffer Cells; Lethal Dose 50; Liver; Liver Diseases; Male; Metallothionein; Necrosis; Phagocytosis; Rats; Rats, Sprague-Dawley; Testis; Tissue Distribution | 1997 |
Nontumorous hepatic pseudolesion around the falciform ligament: prevalence on gadolinium chelate-enhanced MR examination.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium; Humans; Image Processing, Computer-Assisted; Ligaments; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies | 1997 |
The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors.
Topics: Adenoviridae; Animals; Cytokines; DNA; Gadolinium; Gene Expression Regulation, Viral; Genetic Vectors; Kupffer Cells; Liver Diseases; Mice; Mice, Inbred C3H; Mice, SCID; Transgenes | 1997 |
Contrast-enhanced magnetic resonance imaging of the liver.
Topics: Chelating Agents; Contrast Media; Extracellular Space; Ferric Compounds; Gadolinium; Humans; Image Enhancement; Iron Chelating Agents; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Mononuclear Phagocyte System | 1997 |
Multihance clinical pharmacology: biodistribution and MR enhancement of the liver.
Topics: Contrast Media; Gadolinium; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Single-Blind Method | 1998 |
Enhanced magnetic resonance imaging for tissue characterization of liver abnormalities with hepatobiliary contrast agents: an overview of preclinical animal experiments.
Topics: Animals; Cholestasis; Contrast Media; Gadolinium; Liver; Liver Diseases; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Rabbits; Rats | 1998 |
Age-related change in cadmium-induced hepatotoxicity in Wistar rats: role of Kupffer cells and neutrophils.
Topics: Age Factors; Alanine Transaminase; Alkylating Agents; Animals; Anti-Inflammatory Agents; Cadmium; Chemical and Drug Induced Liver Injury; Cyclophosphamide; Dose-Response Relationship, Drug; Escherichia coli; Gadolinium; Glutathione; Kupffer Cells; Lipopolysaccharides; Liver Diseases; Male; Metallothionein; Neutrophils; Rats; Rats, Wistar | 1998 |
Aggravating action of zymosan on acute liver damage in perfused liver of rats treated with D-galactosamine.
Topics: Acute Disease; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Eicosanoids; Gadolinium; Galactosamine; Hemodynamics; Immunohistochemistry; L-Lactate Dehydrogenase; Liver; Liver Circulation; Liver Diseases; Macrophages; Male; Perfusion; Permeability; Rats; Rats, Sprague-Dawley; Reference Values; Zymosan | 1998 |
Gadolinium chloride toxicity in the mouse.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Chemical Analysis; Chemical and Drug Induced Liver Injury; Cholesterol; Contrast Media; Dose-Response Relationship, Drug; Female; Gadolinium; L-Lactate Dehydrogenase; Leukocytes, Mononuclear; Liver Diseases; Male; Mice; Minerals; Necrosis; Serum Globulins; Splenic Diseases | 1998 |
Hepatic lesions: morphologic and functional characterization with multiphase breath-hold 3D gadolinium-enhanced MR angiography--initial results.
Topics: Adult; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Middle Aged | 1999 |
A retrospective analysis of the accuracy of T2-weighted images and dynamic gadolinium-enhanced sequences in the detection and characterization of focal hepatic lesions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Contrast Media; Cysts; Female; Gadolinium; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies; Sensitivity and Specificity | 1999 |
[Magnetic resonance imaging in abdominal pathology].
Topics: Abdomen; Aortic Aneurysm, Abdominal; Aortic Diseases; Bile Duct Neoplasms; Bile Ducts; Carcinoma, Hepatocellular; Cholangitis; Choledochal Cyst; Cholelithiasis; Contrast Media; Cysts; Gadolinium; Hemangioma; Humans; Ischemia; Liver Diseases; Liver Neoplasms; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Mesenteric Vascular Occlusion; Pancreatic Neoplasms; Renal Artery Obstruction | 1999 |
Kupffer cell inactivation delays repair in a rat model of reversible biliary obstruction.
Topics: Animals; Bile Ducts; Bilirubin; Body Weight; Chemical and Drug Induced Liver Injury; Cholestasis, Extrahepatic; Chronic Disease; Collagen; Contrast Media; Disease Models, Animal; Epithelial Cells; Fibrosis; Gadolinium; Hyperplasia; Kupffer Cells; Liver Diseases; Liver Regeneration; Male; Rats; Rats, Sprague-Dawley | 2000 |
Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions: initial observations.
Topics: Adult; Aged; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Focal Nodular Hyperplasia; Gadolinium; Hemangioma; Humans; Image Enhancement; Liver Abscess; Liver Diseases; Liver Neoplasms; Lymphoma; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate; Sensitivity and Specificity | 2000 |
Periportal contrast enhancement and abnormal signal intensity on state-of-the-art MR images.
Topics: Adult; Aged; Biliary Tract Diseases; Contrast Media; Diagnosis, Differential; Female; Fourier Analysis; Gadolinium; Humans; Image Enhancement; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Diseases; Portal Vein; Sensitivity and Specificity | 2001 |
Inhibition of Kupffer cells reduced CXC chemokine production and liver injury.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Chemokine CXCL1; Chemokine CXCL2; Chemokines; Chemokines, CXC; Chemotactic Factors; Gadolinium; Gene Expression; Growth Substances; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Kupffer Cells; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Neutrophils; Peroxidase; Reperfusion Injury; RNA, Messenger; Tumor Necrosis Factor-alpha | 2001 |
Combined use of MR contrast agents for evaluating liver disease.
Topics: Contrast Media; Dextrans; Ferrosoferric Oxide; Gadolinium; Humans; Iron; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Oxides | 2001 |
Multifocal inflammatory pseudotumor of the liver: dynamic gadolinium-enhanced, ferumoxides-enhanced, and mangafodipir trisodium-enhanced MR imaging findings.
Topics: Adult; Contrast Media; Dextrans; Edetic Acid; Female; Ferrosoferric Oxide; Gadolinium; Granuloma, Plasma Cell; Humans; Iron; Liver; Liver Diseases; Magnetic Resonance Imaging; Magnetite Nanoparticles; Manganese; Organometallic Compounds; Oxides; Pyridoxal Phosphate; Suspensions | 2002 |
Synthesis and evaluation of macrocyclic gadolinium chelates as hepatospecific MRI agents.
Topics: Animals; Biliary Tract; Contrast Media; Gadolinium; Haplorhini; Heterocyclic Compounds; Liver; Liver Diseases; Magnetic Resonance Imaging; Mice; Organometallic Compounds; Rats | 2002 |
[VIBE with parallel acquisition technique - a novel approach to dynamic contrast-enhanced MR imaging of the liver].
Topics: Adenoma; Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Cysts; Diagnosis, Differential; Female; Gadolinium; Hemangioma; Humans; Image Enhancement; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged | 2002 |
Focal liver disease: comparison of dynamic contrast-enhanced CT and T2-weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T.
Topics: Adenoma; Adult; Aged; Carcinoma, Hepatocellular; Cysts; Female; Gadolinium; Hemangioma; Humans; Image Enhancement; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Tomography, X-Ray Computed | 1992 |
Magnetic resonance imaging contrast agents.
Topics: Abdomen; Animals; Brain Diseases; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Spinal Diseases | 1992 |
[Diffuse liver parenchymal diseases: the value of MRI compared to sonography and CT].
Topics: Contrast Media; Diagnosis, Differential; Evaluation Studies as Topic; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Prospective Studies; Tomography, X-Ray Computed; Ultrasonography | 1991 |
[Dynamic MR tomography of intrahepatic tumors].
Topics: Adult; Aged; Contrast Media; Cysts; Gadolinium; Gadolinium DTPA; Hemangioma; Humans; Hyperplasia; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Organometallic Compounds; Pentetic Acid | 1989 |
[Magnetic resonance tomography of focal hepatic lesions using the para-magnetic contrast medium, gadolinium DTPA. First clinical results].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Hemangioma; Humans; Hyperplasia; Image Enhancement; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Spectroscopy; Male; Middle Aged; Pentetic Acid | 1986 |
[Magnetic resonance imaging of hepatic tumors using a rapid pulse sequence method].
Topics: Carcinoma, Hepatocellular; Cysts; Female; Gadolinium; Hemangioma; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Spectroscopy; Male; Middle Aged; Pentetic Acid | 1987 |
[Colloidal solution of In-111 for liver scanning].
Topics: Animals; Colloids; Female; Gadolinium; Hodgkin Disease; Humans; Indium; Liver Diseases; Liver Neoplasms; Lymph Nodes; Male; Rabbits; Radioisotopes; Radionuclide Imaging; Rats | 1974 |
Acute miliary necrosis resembling peliosis hepatitis produced by the combination of glucocorticoid and gadolinium chloride.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chlorides; Disease Models, Animal; Female; Gadolinium; Glucocorticoids; Liver; Liver Diseases; Necrosis; Nitriles; Prednisolone; Pregnanes; Purpura; Rats; Triamcinolone | 1972 |